ADGRL4 and central nervous system cancer: VEGF‐A can induce ELTD1 expression and anti‐ELTD1 antibodies can decrease VEGFR2 levels in mouse glioma models (Dieterich et al., 2012; Masiero et al., 2013; Ziegler et al., 2019).